HLB Life Science Co., Ltd. (067630.KQ)
KRW 9780.0
(-1.81%)
KRW 9780.0
(-1.81%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.26 Billion KRW | -51.54% |
| 2022 | 10.86 Billion KRW | 514.36% |
| 2021 | 1.76 Billion KRW | -15.05% |
| 2020 | 2.08 Billion KRW | -70.88% |
| 2019 | 7.14 Billion KRW | 22.14% |
| 2018 | 5.85 Billion KRW | 19.18% |
| 2017 | 4.91 Billion KRW | -31.58% |
| 2016 | 7.17 Billion KRW | 107.91% |
| 2015 | 3.45 Billion KRW | 30.47% |
| 2014 | 2.64 Billion KRW | 0.0% |
| 2013 | - KRW | -100.0% |
| 2012 | 946.45 Million KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 5.23 Billion KRW | -0.55% |
| 2024 Q2 | 5.46 Billion KRW | 4.26% |
| 2023 Q1 | 7.7 Billion KRW | -29.13% |
| 2023 Q3 | 7.67 Billion KRW | 21.48% |
| 2023 Q4 | 5.26 Billion KRW | -31.4% |
| 2023 FY | 5.26 Billion KRW | -51.54% |
| 2023 Q2 | 6.32 Billion KRW | -17.93% |
| 2022 Q3 | 12.58 Billion KRW | 518.29% |
| 2022 FY | 10.86 Billion KRW | 514.36% |
| 2022 Q4 | 10.86 Billion KRW | -13.65% |
| 2022 Q2 | 2.03 Billion KRW | 4.5% |
| 2022 Q1 | 1.94 Billion KRW | 10.11% |
| 2021 Q4 | 1.76 Billion KRW | 15.16% |
| 2021 Q3 | 1.53 Billion KRW | 10.78% |
| 2021 FY | 1.76 Billion KRW | -15.05% |
| 2021 Q1 | 1.6 Billion KRW | -22.98% |
| 2021 Q2 | 1.38 Billion KRW | -13.54% |
| 2020 Q3 | 2.17 Billion KRW | -33.74% |
| 2020 Q4 | 2.08 Billion KRW | -4.07% |
| 2020 Q1 | 3.85 Billion KRW | -46.12% |
| 2020 Q2 | 3.27 Billion KRW | -14.96% |
| 2020 FY | 2.08 Billion KRW | -70.88% |
| 2019 Q1 | 5.76 Billion KRW | -1.46% |
| 2019 FY | 7.14 Billion KRW | 22.14% |
| 2019 Q4 | 7.14 Billion KRW | 2.28% |
| 2019 Q3 | 6.98 Billion KRW | 5.89% |
| 2019 Q2 | 6.6 Billion KRW | 14.44% |
| 2018 Q4 | 5.85 Billion KRW | -0.71% |
| 2018 FY | 5.85 Billion KRW | 19.18% |
| 2018 Q3 | 5.89 Billion KRW | 7.79% |
| 2018 Q2 | 5.46 Billion KRW | -1.09% |
| 2018 Q1 | 5.52 Billion KRW | 12.58% |
| 2017 Q1 | 7.87 Billion KRW | 9.69% |
| 2017 Q2 | 4.18 Billion KRW | -46.87% |
| 2017 Q3 | 4.43 Billion KRW | 6.05% |
| 2017 Q4 | 4.91 Billion KRW | 10.72% |
| 2017 FY | 4.91 Billion KRW | -31.58% |
| 2016 Q4 | 7.17 Billion KRW | -20.02% |
| 2016 FY | 7.17 Billion KRW | 107.91% |
| 2016 Q3 | 8.97 Billion KRW | 73.67% |
| 2016 Q2 | 5.16 Billion KRW | 26.33% |
| 2016 Q1 | 4.09 Billion KRW | 18.49% |
| 2015 Q2 | 5.46 Billion KRW | 35.8% |
| 2015 Q1 | 4.02 Billion KRW | 52.13% |
| 2015 FY | 3.45 Billion KRW | 30.47% |
| 2015 Q3 | 5.97 Billion KRW | 9.37% |
| 2015 Q4 | 3.45 Billion KRW | -42.26% |
| 2014 Q1 | 156.65 Million KRW | 0.0% |
| 2014 Q4 | 2.64 Billion KRW | -37.89% |
| 2014 FY | 2.64 Billion KRW | 0.0% |
| 2014 Q3 | 4.26 Billion KRW | -18.63% |
| 2014 Q2 | 5.23 Billion KRW | 3242.41% |
| 2013 Q2 | 1.04 Billion KRW | 14.44% |
| 2013 Q3 | 1.28 Billion KRW | 23.59% |
| 2013 Q4 | - KRW | -100.0% |
| 2013 FY | - KRW | -100.0% |
| 2013 Q1 | 909.41 Million KRW | -3.91% |
| 2012 FY | 946.45 Million KRW | 0.0% |
| 2012 Q3 | - KRW | 0.0% |
| 2012 Q4 | 946.45 Million KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|